SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003177
Filing Date
2022-03-09
Accepted
2022-03-09 07:46:15
Documents
13
Period of Report
2022-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20220309.htm   iXBRL 8-K 54559
2 EX-99.1 oncr-ex99_1.htm EX-99.1 202022
  Complete submission text file 0000950170-22-003177.txt   390128

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20220309.xsd EX-101.SCH 2480
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20220309_pre.xml EX-101.PRE 10320
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20220309_lab.xml EX-101.LAB 13996
7 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20220309_htm.xml XML 4882
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 22723932
SIC: 2834 Pharmaceutical Preparations